How a patent dispute with 10x helped decimate NanoString’s stock price
Recent $31 million damages award has dealt a further blow to the company's faltering share value
Recent $31 million damages award has dealt a further blow to the company's faltering share value
The latest AST Patent Deals Report shows assets being transacted by the likes of Huawei and Intel on the sell side, and Philips and Softbank on the buy side
Following a catastrophic loss of exclusivity stateside, the company has received a boost in the EU
12 May 2023
Delaware jury rules against the federal government in a big-money patent infringement suit being closely watched by policymakers.
11 May 2023
Following a lull in lawsuits, several new biologics have become the subject of litigation in recent months
05 May 2023
The vaccine maker has suffered another setback, but its fight to deflect infringement responsibility to the US government continues
02 May 2023
Planned change will make UPC more attractive to life sciences companies
28 April 2023
Various provisions in the USPTO’s rulemaking proposal favour patent owners and others lean towards petitioners, yet one thing is certain: chief IP officers must make their voices heard
26 April 2023
Illumina settlement and clean sweep at the PTAB have added to earlier $273 million damages award
26 April 2023
The company took a calculated risk by paying billions for drug while a slew of patent challenges were ongoing
25 April 2023
The Enlarged Board of Appeal's ruling in G2/21 has significant implications for the use of post-filed data
21 April 2023
Deal hoped to stave off investor concerns about expiring patents and diversify product pipeline
20 April 2023
Unlock unlimited access to all IAM content